{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:19:34Z","timestamp":1774523974321,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Second-line antiretroviral therapy (ART) failure remains a challenge in HIV Programs. We conducted a cross-sectional study among people living with HIV on second-line ART in Eastern Uganda to determine the prevalence and associated factors of virological failure and to assess elevated serum bilirubin as a surrogate marker of adherence. The prevalence of virological failure was 7.5%. Elevated bilirubin showed poor sensitivity and specificity for predicting adherence or virological failure. The findings highlight the need for routine viral load monitoring, as bilirubin is not a reliable surrogate marker of treatment adherence or virological failure.<\/jats:p>","DOI":"10.1186\/s12981-026-00861-w","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:01:49Z","timestamp":1771506109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Second-line virologic failure and elevated bilirubin as a potential surrogate marker of ART adherence among people living with HIV in Eastern Uganda"],"prefix":"10.1186","volume":"23","author":[{"given":"Simiyu Melap","family":"Lynnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob Stanley","family":"Iramiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Nekaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Okware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Abwola","family":"Olwedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Epuitai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Oboth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Itabangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia V. N.","family":"Ssenyonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Nteziyaremye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Okia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"861_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0885-3924(00)00245-1","volume":"21","author":"JR Brechtl","year":"2001","unstructured":"Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B. The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. J Pain Symptom Manage. 2001;21(1):41\u201351.","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"861_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1034\/j.1600-0714.2000.290708.x","volume":"29","author":"AM Schmidt-Westhausen","year":"2000","unstructured":"Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med. 2000;29(7):336\u201341.","journal-title":"J Oral Pathol Med"},{"key":"861_CR3","volume":"14","author":"M Sam","year":"2021","unstructured":"Sam M, Masaba JPM, Alio D, Byakika-Tusiime J. Treatment failure and associated factors among individuals on second line antiretroviral therapy in Eastern Uganda: a retrospective cohort study. Infect Dis Res Treat. 2021;14: 11786337211014518.","journal-title":"Infect Dis Res Treat"},{"issue":"7","key":"861_CR4","volume":"7","author":"R Smith","year":"2022","unstructured":"Smith R, Villanueva G, Probyn K, Sguassero Y, Ford N, Orrell C, et al. Accuracy of measures for antiretroviral adherence in people living with HIV. Cochrane Database Syst Rev. 2022;7(7):Cd013080.","journal-title":"Cochrane Database Syst Rev"},{"key":"861_CR5","first-page":"205","volume":"10","author":"P Panagopoulos","year":"2017","unstructured":"Panagopoulos P, Maltezos E, Hatzakis A, Paraskevis D. Hyperbilirubinemia in Atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele. Pharmacogenomics Pers Med. 2017;10:205\u20138.","journal-title":"Pharmacogenomics Pers Med"},{"issue":"5","key":"861_CR6","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1016\/S2352-3018(25)00074-8","volume":"12","author":"D Brink","year":"2025","unstructured":"Brink D, Martin-Hughes R, Bowring AL, Wulan N, Burke K, Tidhar T, et al. Impact of an international HIV funding crisis on HIV infections and mortality in low-income and middle-income countries: a modelling study. Lancet HIV. 2025;12(5):e346\u201354.","journal-title":"Lancet HIV"},{"issue":"7","key":"861_CR7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/07399332.2019.1703991","volume":"41","author":"C Izugbara","year":"2020","unstructured":"Izugbara C, Wekesah FM, Sebany M, Echoka E, Amo-Adjei J, Muga W. Availability, accessibility and utilization of post-abortion care in Sub-Saharan Africa: a systematic review. Health Care Women Int. 2020;41(7):732\u201360.","journal-title":"Health Care Women Int"},{"issue":"8","key":"861_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/QAD.0b013e328351f5b2","volume":"26","author":"O Ajose","year":"2012","unstructured":"Ajose O, Mookerjee S, Mills EJ, Boulle A, Ford N. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. AIDS. 2012;26(8):929\u201338.","journal-title":"AIDS"},{"key":"861_CR9","unstructured":"The Uganda Ministry of Health. Consolidated guidelines for prevention. In: diseases C, editor. 2016."},{"issue":"7","key":"861_CR10","doi-asserted-by":"publisher","first-page":"e0289450","DOI":"10.1371\/journal.pone.0289450","volume":"19","author":"G Ayenew","year":"2024","unstructured":"Ayenew G, Agumas Y, Shibabaw T, Getaneh G, Getie M. Determinants of virological failure among HIV clients on second-line antiretroviral treatment at Felege-hiwot and university of Gondar comprehensive specialized hospitals in the Amhara Region, Northwest ethiopia: a case-control study. PLoS One. 2024;19(7):e0289450.","journal-title":"PLoS One"},{"key":"861_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-28","volume":"14","author":"M Paul","year":"2014","unstructured":"Paul M, Gemzell-Danielsson K, Kiggundu C, Namugenyi R, Klingberg-Allvin M. Barriers and facilitators in the provision of post-abortion care at district level in central Uganda - a qualitative study focusing on task sharing between physicians and midwives. BMC Health Serv Res. 2014;14:28.","journal-title":"BMC Health Serv Res"},{"key":"861_CR12","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2018.29.191.11940","volume":"29","author":"P Kazooba","year":"2018","unstructured":"Kazooba P, Mayanja BN, Levin J, Masiira B, Kaleebu P. Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004\u20132011. Pan Afr Med J. 2018;29:191.","journal-title":"Pan Afr Med J"},{"issue":"2","key":"861_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/QAI.0b013e318142aabb","volume":"46","author":"JH Samet","year":"2007","unstructured":"Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007;46(2):194\u20139.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00861-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:44:22Z","timestamp":1774521862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00861-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00861-w","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the Mbale Regional Referral Hospital Research Ethics Committee (MRRH-2022-204). Permission to collect data was sought from the administration of MRRH and Tororo Hospital. Written informed consent was obtained from all participants who completed the questionnaires individually to ensure privacy, confidentiality, and anonymity. Participation was voluntary, and participants could withdraw from the study at any time without penalty.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}